Theraclion Stock OTC Markets
Stocks
TCLIF
FR0010120402
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
12:12:18 25/09/21 am AEST
|
5-day change | 1st Jan Change | ||
| 2.280 USD | +9.62% |
|
+328.57% | +612.50% |
| 24/07 | Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026 | CI |
| 09/07 | Theraclion Announces Board Changes | CI |
| Market Cap | 48.32M 55.95M 45.37M 41.31M 77.62M 5.35B 78.75M 532M 208M 2.68B 210M 205M 8.92B | P/E 2024 |
-2.66x | P/E 2025 | -6.33x |
|---|---|---|---|---|---|
| Enterprise Value | 56.18M 65.05M 52.74M 48.02M 90.23M 6.22B 91.54M 619M 242M 3.12B 244M 239M 10.37B | EV / Sales 2024 |
22.5x | EV / Sales 2025 | 55.4x |
| Free-Float |
54.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +9.62% | ||
| 1 week | +328.57% | ||
| Current month | +328.57% | ||
| 1 month | +328.57% | ||
| 3 months | +328.57% | ||
| 6 months | +612.50% | ||
| Current year | +612.50% |
| Current year | 0.53 |  | 2.28 |
| 1 year | 0.53 | | 2.28 |
| 3 years | 0 | | 2.28 |
| 5 years | 0 | | 2.28 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 24/05/2023 |
Julie Veisseire
DFI | Director of Finance/CFO | - | - |
Alexandra Rocher
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mehdi El Glaoui
BRD | Director/Board Member | - | 22/06/2021 |
Cédric Bellanger
BRD | Director/Board Member | - | 28/01/2022 |
Lijuan Deng
BRD | Director/Board Member | - | 29/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.62% | +328.57% | - | - | 56.54M | |
| -0.47% | -1.43% | +19.73% | +10.71% | 218B | |
| +0.09% | -1.04% | -3.93% | -19.84% | 142B | |
| -1.06% | +3.04% | -18.73% | +30.41% | 139B | |
| -0.77% | +4.30% | -50.15% | -0.06% | 75.11B | |
| -0.86% | +1.21% | +16.04% | +15.26% | 52.8B | |
| -0.79% | -1.29% | -17.14% | -16.13% | 50.66B | |
| -0.05% | +1.70% | +24.54% | +22.32% | 41.95B | |
| -1.07% | +0.22% | +39.85% | +48.34% | 40.49B | |
| -1.79% | +0.84% | -1.40% | +2.41% | 33.28B | |
| Average | +0.43% | +1.61% | +0.98% | +10.38% | 88.17B | |
| Weighted average by Cap. | -0.36% | +1.12% | -0.09% | +8.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 830K 961K 779K 710K 1.33M 91.91M 1.35M 9.14M 3.58M 46.04M 3.61M 3.53M 153M | 652K 755K 612K 557K 1.05M 72.18M 1.06M 7.18M 2.81M 36.15M 2.83M 2.77M 120M |
| Net income | -5.76M -6.67M -5.41M -4.92M -9.25M -637M -9.38M -63.4M -24.81M -319M -25.01M -24.48M -1.06B | -5.69M -6.59M -5.34M -4.86M -9.14M -630M -9.27M -62.66M -24.52M -316M -24.72M -24.19M -1.05B |
| Net Debt | 3.41M 3.95M 3.2M 2.92M 5.48M 378M 5.56M 37.56M 14.7M 189M 14.82M 14.5M 630M | 7.85M 9.09M 7.37M 6.71M 12.61M 869M 12.79M 86.47M 33.84M 435M 34.11M 33.38M 1.45B |
Employees
36
Calendar
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHE Stock
- TCLIF Stock
Select your edition
All financial news and data tailored to specific country editions
